LVR-Klinikum Düsseldorf Hospital of the Heinrich-Heine University ...

LVR-KLINIKUM DÜsseLDORF – hOsPITaL OF The heINRIch-heINe UNIVeRsITY DÜsseLDORF
ces treatment response to atypical antipsychotics in schizophrenia.
Pharmacogenetics and Genomics 19: 91–4
Mössner R, Schuhmacher A, Wagner M, Quednow BB, Frommann I,
Kühn K, Schwab S, Rietschel M, Falkai P, Wölwer W, Ruhrmann S,
Bechdolf A, Gaebel W, Klosterkötter J, Maier W (2009): DAOA/G72
predicts the progression of prodromal syndromes to first episode
psychosis. Eur Arch Psychiat Clin Neurosc, Sep 10 (Epub ahead of
print)
Reske M, Habel U, Kellermann T, Backes V, Jon Shah N, von Wilmsdorff
M, Gaebel W, Zilles K, Schneider F (2009): Differential brain
activation during facial emotion discrimination in first-episode
schizophrenia. J Psychiatr Res 43: 592–599
Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Schmauss
M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter
J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar
M, Möller HJ, Riedel M (2009): Outcome of suicidal patients
with schizophrenia:results from a naturalistic study. Acta Psychiatr
Scand (Epub ahead of print)
Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Messer T,
Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Huff W, Heuser
I, Maier W, Lemke MR, Rüther E, Buchkremer G, Gastpar M,
Möller HJ, Riedel M (2009): Defining and predicting functional outcome
in schizophrenia and schizophrenia spectrum disorders.
Schizophr Res 113: 210–217
Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Messer T,
Laux G, Pfeiffer H, Naber D, Schmidt LG. Gaebel W, Klosterkötter
J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar
M, Möller HJ, Riedel M (2009): Attitude towards adherence in patients
with schizophrenia at discharge. J Psychiatr Res 43: 1294–
1301
Schmidt-Kraepelin C, Janssen B, Gaebel W (2009): Prevention of rehospitalization
in schizophrenia: results of an integrated care project
in Germany. Eur Arch Psychiatry Clin Neurosci 259 (Suppl):
205–212
Schumacher A, Mössner R, Quednow BB, Kühn K, Wagner M, Cvetanovska
G, Rujescu D, Zill P, Möller HJ, Rietschel M, Franke P,
Wölwer W, Gaebel W, Maier W (2009): Influence of 5-HT3 receptor
subunit genes 5-HT3A, B, C, D, E on treatment response to antipsychotics
in schizophrenia. Pharmacogenetics and Genomics 19:
843–851
Seemüller F, Möller HJ, Obermeier M, Adli M, Bauer M, Kronmüller
K, Holsboer F, Brieger P, Laux G, Bender W, Heuser I, Zeiler J,
Gabel W, Schennach R, Henkel V, Riedel M (2009): Do efficacy and
effectiveness samples differ in antidepressant treatment outcome)
J Clin Psychiatry (in press)
Seemüller F, Riedel M, Obermeier M, Bauer M, Adli M, Mundt C,
Holsboer F, Brieger P, Lauc G, Bender W, Heuser I, Zeiler J, Gaebel
W, Jäger M, Henkel V, Möller HJ (2009): The controversial link
between antidepressants and suicidality risks in adults: data from
a naturalistic study on a large sample of in-patients with a major
depressive episode. Int J Neuropsychopharm 12: 181–189
136
Sielk M, Altiner A, Janssen B, Becker N, de Pilars M, Abholz HH
(2009): Prävalenz und Diagnostik depressiver Störungen in der All-
gemeinarztpraxis. Psychiat Prax 36: 169–174
Simons G, Ellgring H, Beck-Dossler K, Gaebel W, Wölwer W (2009):
Facial expression in male and female schizophrenia patients. Eur
Arch Psychiat Clin Neurosc, Oct 9 (Epub ahead of print)
Thornicroft G, Brohan E, Rose D, Sartorius N, Leese M, for the INDI-
GO Study Group (2009): Global pattern of experienced and anticipated
discrimination against people with schizophrenia: a crosssectional
survey. The Lancet 373: 408–415
Treutlein J, Cichon S, Ridinger M, Wodarz N, Soyka M, Zill P, Maier
W, Moessner R, Gaebel W, Dahmen N, Fehr C, Scherbaum N, Steffens
M, Ludwig KU, Frank J, Wichmann HE, Schreiber S, Dragano
N, Sommer WH, Leonardi-Essmann F, Lourdusamy A, Gebicke-
Haerter P, Wienker TF, Sullivan PF, Nöthen MM, Kiefer F, Spanagel
R, Mann K, Rietschel M (2009): Genome-wide association study
of alcohol dependence. Arch Gen Psychiatry 66: 773–784
Wernicke C, Reese J, Kraschewski A, Winterer G, Rommelspacher H,
Gallinat J (2009): Distinct haplogenotypes of the dopamine D2 receptor
gene are associated with non-smoking behaviour and daily
cigarette consumption. Pharmacopsychiatry 42: 41–50
Wittorf A, Jacobi U, Bechdolf A, Müller B, Sartory G, Wagner M, Wiedemann
G, Wölwer W, Herrlich J, Buchkremer G, Klingberg S
(2009): The influence of baseline symptoms and insight on the therapeutic
alliance early in the treatment of schizophrenia. European
Psychiatry 24: 259–67
Wobrock T, Falkai P, Schneider-Axmann T, Pfeiffer U, Wölwer W,
Gae bel W (2009): Effects of abstinence on brain morphology in al-
coholism: A MRI study. Eur Arch Psychiat Clin Neurosc 259: 143–150
Wobrock T, Gruber O, Schneider-Axmann T, Wölwer W, Gaebel W,
Riesbeck M, Maier W, Klosterkötter J, Schneider F, Buchkremer
G, Möller HJ, Schmitt A, Bender S, Schlösser R, Falkai P (2009):
Internal capsule size associated with outcome in first-episode
schizophrenia. Eur Arch Psychiat Clin Neurosc 259: 278–283
Wobrock T, Weinmann S, Falkai P, Gaebel W (2009): Quality assurance
in psychiatry: quality indicators and guideline implementation.
Arch Psychiatry Clin Neurosci (Suppl) 259: 219–226
Wölwer W, Frommann N (2009): Entrenamiento en el reconocimiento
de afectos – Programa especifico para el tratamiento de los trastornos
cognitivo-sociales de los pacientes esquizofrénicos. Rehabilitacion
Psicosocial (in press)
Wölwer W, Drusch K (2009): Neuropsychologische Aspekte psychischer
Störungen über die Lebensspanne. Die Psychiatrie 6: 184–190
Zielasek J, Freyberger HJ, Jänner M, Kapfhammer HP, Sartorius N,
Stieglitz RD, Gaebel W (2009): Assessing the opinions and experiences
of German-speaking psychiatrists regarding necessary
changes for the eleventh revision of the mental disorders chapter
of the intenational classification of disorders (ICD-11). Eur Psychiatry
(in press)
Zielasek J, Gaebel W (2009) Modularity in philosophy, the neuroscience,
and psychiatry. Poiesis & Praxis 6: 93–108